Breast cancer has been divided into at least three subtypes (Luminal, HER2-enriched, and triple-negative) based on the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). Here, PGR is linked to breast carcinoma.